Vaxil Bio Ltd. | Cash Flow


No data

About Vaxil Bio

View Profile
Address
First Canadian Place, 34th Floor
Toronto Ontario M5X 1A9
Canada
Employees -
Website http://vxlbio.com
Updated 07/08/2019
Vaxil Bio Ltd. engages in the development of immunotheraphies such as neoantigen-like peptide products, and antibodies to treat cancer and infectious diseases. Its pipeline consists of ImMucin, SPmAb2, SPmAb6, and MTbuVax. The company was founded on September 13, 2013 and is headquartered in Toronto, Canada.